Literature DB >> 33126007

Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis.

Lai Yi1, Libo Zhou2, Jinxia Luo3, Qiuhong Yang4.   

Abstract

BACKGROUND: Acute myeloid leukemia (AML) is characterized by malignant clonal disorder of blood cells with high relapse rate and low survival rate. Circular RNAs (circRNAs) have shown their important regulatory roles in AML progression. Here, we intended to disclose the role of circular RNA protein tyrosine kinase 2 (circ-PTK2) in the progression of AML and illustrate the potential working mechanisms.
METHODS: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and colony formation assay were conducted to analyze cell proliferation ability, and the apoptosis rate was assessed by flow cytometry. Dual-luciferase reporter assay was used to validate the direct interaction between microRNA-330-5p (miR-330-5p) and circ-PTK2 or forkhead box M1 (FOXM1).
RESULTS: Circ-PTK2 was highly expressed in AML. Circ-PTK2 interference suppressed the proliferation and triggered the apoptosis of AML cells. Circ-PTK2 directly bound to miR-330-5p. Si-circ-PTK2-mediated inhibition on the malignant behaviors of AML cells was partly counteracted by the addition of anti-miR-330-5p. MiR-330-5p directly interacted with FOXM1 messenger RNA (mRNA), and FOXM1 overexpression partly reversed miR-330-5p-induced influence in AML cells. Circ-PTK2 up-regulated FOXM1 expression through sponging miR-330-5p in AML cells.
CONCLUSION: Circ-PTK2 promoted the proliferation and hampered the apoptosis of AML cells through targeting miR-330-5p/FOXM1 axis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Apoptosis; FOXM1; Proliferation; circ-PTK2; miR-330-5p

Mesh:

Substances:

Year:  2020        PMID: 33126007     DOI: 10.1016/j.bcmd.2020.102506

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  9 in total

1.  Circ-SFMBT2 facilitates the malignant growth of acute myeloid leukemia cells by modulating miR-582-3p/ZBTB20 pathway.

Authors:  Wei Chang; Zhen Shang; Xi Ming; Jiaying Wu; Yi Xiao
Journal:  Histol Histopathol       Date:  2021-11-26       Impact factor: 2.303

2.  Homo sapiens circular RNA 0003602 (Hsa_circ_0003602) accelerates the tumorigenicity of acute myeloid leukemia by modulating miR-502-5p/IGF1R axis.

Authors:  Qidong Ye; Nan Li; Kai Zhou; Cong Liao
Journal:  Mol Cell Biochem       Date:  2022-01-06       Impact factor: 3.396

Review 3.  Roles of circRNAs in hematological malignancies.

Authors:  Fahua Deng; Chengsi Zhang; Tingting Lu; Ezhong Joshua Liao; Hai Huang; Sixi Wei
Journal:  Biomark Res       Date:  2022-07-15

Review 4.  Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.

Authors:  Javeria Qadir; Feiya Li; Burton B Yang
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

5.  Mechanism of miR-365 in regulating BDNF-TrkB signal axis of HFD/STZ induced diabetic nephropathy fibrosis and renal function.

Authors:  Peng Zhao; Xiaqiu Li; Yang Li; Jiaying Zhu; Yu Sun; Jianli Hong
Journal:  Int Urol Nephrol       Date:  2021-04-21       Impact factor: 2.370

Review 6.  Circular RNAs in acute myeloid leukemia.

Authors:  Vijendra Singh; Mohammed Hafiz Uddin; Jeffrey A Zonder; Asfar S Azmi; Suresh Kumar Balasubramanian
Journal:  Mol Cancer       Date:  2021-11-18       Impact factor: 27.401

7.  Serum hsa_circ_0079480 is a novel prognostic marker for acute myeloid leukemia.

Authors:  Liang Guo; Ru Kou; Yanping Song; Guang Li; Xueyou Jia; Zhenzhen Li; Yunjie Zhang
Journal:  J Clin Lab Anal       Date:  2022-03-17       Impact factor: 2.352

Review 8.  Advances in the Study of circRNAs in Hematological Malignancies.

Authors:  Jingyi Du; Feiyu Jia; Lijuan Wang
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

Review 9.  Circular RNAs Activity in the Leukemic Bone Marrow Microenvironment.

Authors:  Francesca Liccardo; Alessia Iaiza; Martyna Śniegocka; Silvia Masciarelli; Francesco Fazi
Journal:  Noncoding RNA       Date:  2022-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.